Insider Trading History of Carter Michael G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Carter Michael G since 2010. The trader's CIK number is 1265793. At the time of the last reporting, Carter Michael G was the Director of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT). Also see all insider trading activities at Oncternal Therapeutics, Inc..

Note that in the past CARTER MICHAEL G also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Oncternal Therapeutics, Inc. (ONCT) by Carter Michael G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ONCT 71,429 $150,000 0 $0 0 $0

Yearly summary of insider trading at Cancervax Corp (MITI) by Carter Michael G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 MITI 0 $0 0 $0 757 $2,445

Yearly summary of insider trading at Santarus Inc (SNTS) by Carter Michael G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 SNTS 0 $0 32,000 $487,040 0 $0
2012 SNTS 0 $0 0 $0 32,000 $37,760


Insider trading activities at 3 companies by Carter Michael G:

1. Oncternal Therapeutics, Inc. (ONCT)

2. Cancervax Corp (MITI)

3. Santarus Inc (SNTS)

Table 1. Insider trading of Oncternal Therapeutics, Inc. (ONCT) by Carter Michael G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-09-01 ONCT Buy 71,429 2.10 150,000

Table 2. Insider trading of Cancervax Corp (MITI) by Carter Michael G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-10-15 MITI Option Ex 757 3.23 2,445

Table 3. Insider trading of Santarus Inc (SNTS) by Carter Michael G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-03-07 SNTS Sale 32,000 15.22 487,040
2012-10-25 SNTS Option Ex 32,000 1.18 37,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carter Michael G (Director of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.